News

The company reported net sales of $615 million for the three months ended February 28, 2009, an increase of 2%, compared to $603.1 million for the three months

The contract, valued at GBP1.1 million, is for process development and GMP manufacture of specific antibodies. This contract will be delivered by mid-2010. The company also signed a

Mr Hawkins spent the past seven years in founder and leadership roles developing and commercializing medical devices for incubators funded by Three Arch Partners, Frazier Healthcare, Prospect Ventures,

In addition to reducing the size of its management team, the company announced that Bernard Boudreau, Edgar Parker, Aditya Jah, Vasu Chanchlani and Michael Sefton have all resigned

Under the terms of the arrangement, GVK Biosciences and Excel will help sponsors conduct and manage Phase II-IV clinical trials, statistical analysis and medical writing. Any India trial

Sinovac Biotech, a China-based biopharmaceutical company, has reported a net income of $2.4m, or $0.06 per diluted share, for the fourth quarter of 2008, compared to $2m, or

According to Sun Pharma, these oxycodone tablets are therapeutically equivalent to Roxicodone tablets from Xanodyne Pharmaceuticals and are available in three strengths: 5mg, 15mg and 30mg. Oxycodone is

The companies have agreed to offer their services together to parties such as pharmaceutical companies, who may be seeking a patient-friendly intranasal Phylomer peptide developed against their target

The funding was triggered by the company’s achievement of a major milestone towards the development of its image guided cancer therapy device, the Renaissance system. The financing was